Tuomas Tenkanen
Directeur Général chez Mobidiag Oy
Profil
Tuomas Tenkanen is currently the Chief Executive Officer & Director at Mobidiag Oy since 2013 and the Chairman at TJT Technologies Oy since 2011.
Previously, he worked as the Director of Research & Development at Finnzymes Oy.
He also served as the Director at Aiforia Technologies Oyj from 2013 to 2017.
Mr. Tenkanen completed his undergraduate degree at Aalto University School of Science & Technology.
Postes actifs de Tuomas Tenkanen
| Sociétés | Poste | Début |
|---|---|---|
Mobidiag Oy
 Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | Directeur Général | 01/01/2013 |
TJT Technologies Oy
 TJT Technologies Oy BiotechnologyHealth Technology TJT Technologies Oy is a Finnish company that specializes in researching and developing biotechnology products. The private company is based in Helsinki, Finland. | Président | 01/01/2011 |
Anciens postes connus de Tuomas Tenkanen
| Sociétés | Poste | Fin |
|---|---|---|
| AIFORIA TECHNOLOGIES OYJ | Directeur/Membre du Conseil | 01/01/2017 |
Finnzymes Oy
 Finnzymes Oy Pharmaceuticals: MajorHealth Technology The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise. | Directeur Technique/Scientifique/R&D | - |
Formation de Tuomas Tenkanen
| Aalto University School of Science & Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AIFORIA TECHNOLOGIES OYJ | Technology Services |
| Entreprise privées | 3 |
|---|---|
Mobidiag Oy
Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | Commercial Services |
Finnzymes Oy
Finnzymes Oy Pharmaceuticals: MajorHealth Technology The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise. | Health Technology |
TJT Technologies Oy
TJT Technologies Oy BiotechnologyHealth Technology TJT Technologies Oy is a Finnish company that specializes in researching and developing biotechnology products. The private company is based in Helsinki, Finland. | Health Technology |
